Featured Research

from universities, journals, and other organizations

Vaccine Records Of Internationally Adopted Children May Not Reflect Protection Against Disease

Date:
May 4, 2009
Source:
JAMA and Archives Journals
Summary:
Children adopted from countries such as Russia, China and Guatemala may not be protected against polio, measles or other diseases despite records indicating they have been immunized, according to a new article.

Children adopted from countries such as Russia, China and Guatemala may not be protected against polio, measles or other diseases despite records indicating they have been immunized, according to a new report.

U.S. families have adopted almost 250,000 foreign-born children in the last 15 years, according to background information in the article. Many of these children were living in orphanages or other institutional settings with few resources and are likely to have incomplete immunization records or none at all. When valid written records do exist, the American Academy of Pediatrics Committee on Infectious Disease advises that they could be considered as evidence of previous vaccination. However, there are reasons to suspect that these records may not accurately reflect immunity, including "documentation inaccuracies, lack of vaccine potency and impaired immune response, possibly due to stress or malnutrition."

Emaculate Verla-Tebit, Ph.D., and colleagues at Case Western Reserve University School of Medicine, Cleveland, obtained data from 465 children who visited the International Adoption Clinic at Rainbow Babies and Children's Hospital between 2001 and 2006 and who presented for care within 180 days of arrival to the United States. Most of the adopted children came from Russia (41.7 percent), China (20.9 percent) or Guatemala (15.7 percent). Immunization records were available for 397 (85.4 percent) of adoptees (average age 19.4 months). Blood samples were obtained and tested for evidence of immunity against diphtheria, tetanus, measles, hepatitis B and polio.

Evidence of immunity was found in:

  • 87.2 percent of the 203 children with three or more tetanus vaccinations
  • 94.6 percent of the 205 children with three or more diphtheria vaccinations
  • a differing number of the 216 children with three or more polio vaccines based on disease type—58.3 percent against polio type 1, 82.4 percent against polio type 2, and 51.9 percent against polio type 3
  • 94.1 percent of the 170 children with two or more hepatitis B vaccinations
  • 80.8 percent of the 99 children with measles vaccinations

Children from China were less likely to have immunity than those from Russia. A total of 5.5 percent of the adoptees had acute malnutrition and 15.4 percent had chronic malnutrition; however, nutrition status was not associated with protective immunity.

"Our results suggest that the predictive value of immunization records in international adoptees may be limited and associated with birth country," the authors write. "Reasons that have been proposed include falsification of vaccine certificates, inaccurate entries and lack of vaccine potency."

Revaccination may be a cost-effective option for parents whose children do not show immunity, the authors note. Parents of children in the current study chose to revaccinate between 5 percent and 21 percent of the time, depending on the vaccine type. "Immunization records should not be accepted as evidence of protective immunity. Parents should be well informed and supported to choose between revaccination or vaccination, based on serologic [blood] testing," they conclude.

This study was supported by a grant from the National Institutes of Health.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Cite This Page:

JAMA and Archives Journals. "Vaccine Records Of Internationally Adopted Children May Not Reflect Protection Against Disease." ScienceDaily. ScienceDaily, 4 May 2009. <www.sciencedaily.com/releases/2009/05/090504161607.htm>.
JAMA and Archives Journals. (2009, May 4). Vaccine Records Of Internationally Adopted Children May Not Reflect Protection Against Disease. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/05/090504161607.htm
JAMA and Archives Journals. "Vaccine Records Of Internationally Adopted Children May Not Reflect Protection Against Disease." ScienceDaily. www.sciencedaily.com/releases/2009/05/090504161607.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins